| RE50319 | Compounds and methods for treating cancer | Nov 10, 22 | Mar 04, 25 | Dana-Farber Cancer Institute, Inc. |
| RE49229 | Methods and compositions for treating malignant tumors associated with KRAS mutation | Feb 28, 20 | Oct 04, 22 | Nitto Denko Corporation |
| RE49223 | Water-soluble fluorescence compound and method for preparing the same | Apr 29, 20 | Sep 27, 22 | SNU R&DB Foundation; Global Frontier Center for Multiscale Energy Systems; |
| RE48887 | RNA interference compositions and methods for malignant tumors | Sep 19, 19 | Jan 11, 22 | Nitto Denko Corporation |
| RE48856 | Inhibition of NEAT1 for treatment of solid tumors | Oct 10, 19 | Dec 21, 21 | VIB VZW; KATHOLIEKE UNIVERSITEIT LEUVEN, K.U. LEUVEN R&D; |
| RE48732 | Methods and compositions for the selection and optimization of oligonucleotide tag sequences | Jul 19, 18 | Sep 14, 21 | Gen-Probe Incorporated |
| RE48345 | Compositions and methods for inhibiting gene expression of hepatitis B virus | Aug 19, 16 | Dec 08, 20 | Arrowhead Pharmaceuticals, Inc. |
| RE48253 | Methotrexate adjuvants to reduce toxicity and methods for using the same | Jun 29, 18 | Oct 13, 20 | Tosk, Inc. |
| RE48171 | Substituted nucleosides, nucleotides and analogs thereof | Sep 13, 18 | Aug 25, 20 | Janssen BioPharma, Inc. |
| RE48060 | Antisense modulation of PTP1B expression | Jun 15, 16 | Jun 23, 20 | Ionis Pharmaceuticals, Inc. |
| RE47797 | Intermediates for the preparation of analogs of halichondrin B | Apr 03, 18 | Jan 07, 20 | EISAI R&D MANAGEMENT CO., LTD. |
| RE47769 | Antisense oligonucleotides for inducing exon skipping and methods of use thereof | Nov 11, 16 | Dec 17, 19 | THE UNIVERSITY OF WESTERN AUSTRALIA |
| RE47741 | Antibacterial aminoglycoside analogs | Jun 14, 18 | Nov 26, 19 | Achaogen Inc. |
| RE47691 | Antisense oligonucleotides for inducing exon skipping and methods of use thereof | Jul 10, 17 | Nov 05, 19 | THE UNIVERSITY OF WESTERN AUSTRALIA |
| RE47589 | Phosphoramidate compounds and methods of use | Sep 29, 16 | Sep 03, 19 | NuCana PLC |
| RE47351 | receptor agonists | Jun 27, 17 | Apr 16, 19 | Gilead Sciences, Inc. |
| RE47301 | Process for preparing an A2A-adenosine receptor agonist and its polymorphs | Jul 19, 17 | Mar 19, 19 | Gilead Sciences, Inc. |
| RE46965 | Intermediates for the preparation of analogs of Halichondrin B | Jun 24, 13 | Jul 24, 18 | Eisai R & D Management Co., Ltd. |
| RE46955 | Sulfated oligosaccharide derivatives | Sep 09, 16 | Jul 17, 18 | Progen PG500 Series Pty Ltd |
| 9999652 | Methods and devices for bone infection treatment selection | Apr 08, 15 | Jun 19, 18 | Children's Hospital Medical Center |